Computational Medicine Program, Department of Pharmacology, Department of Pathology and Lab Medicine, McAllister Heart Institute, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
Cells. 2021 Nov 11;10(11):3121. doi: 10.3390/cells10113121.
Heat shock proteins (HSPs) are a family of molecular chaperones that regulate essential protein refolding and triage decisions to maintain protein homeostasis. Numerous co-chaperone proteins directly interact and modify the function of HSPs, and these interactions impact the outcome of protein triage, impacting everything from structural proteins to cell signaling mediators. The chaperone/co-chaperone machinery protects against various stressors to ensure cellular function in the face of stress. However, coding mutations, expression changes, and post-translational modifications of the chaperone/co-chaperone machinery can alter the cellular stress response. Importantly, these dysfunctions appear to contribute to numerous human diseases. Therapeutic targeting of chaperones is an attractive but challenging approach due to the vast functions of HSPs, likely contributing to the off-target effects of these therapies. Current efforts focus on targeting co-chaperones to develop precise treatments for numerous diseases caused by defects in protein quality control. This review focuses on the recent developments regarding selected HSP70/HSP90 co-chaperones, with a concentration on cardioprotection, neuroprotection, cancer, and autoimmune diseases. We also discuss therapeutic approaches that highlight both the utility and challenges of targeting co-chaperones.
热休克蛋白(HSPs)是分子伴侣家族的一员,它们调节重要的蛋白质重折叠和分类决策,以维持蛋白质的内稳态。许多共伴侣蛋白直接相互作用并修饰 HSP 的功能,这些相互作用影响蛋白质分类的结果,影响从结构蛋白到细胞信号转导介质的所有方面。伴侣/共伴侣机制可以防止各种应激源的侵害,以确保细胞在面临应激时的功能。然而,伴侣/共伴侣机制的编码突变、表达变化和翻译后修饰可以改变细胞应激反应。重要的是,这些功能障碍似乎与许多人类疾病有关。针对伴侣蛋白的治疗是一种有吸引力但具有挑战性的方法,因为 HSPs 的功能非常广泛,这可能导致这些治疗的脱靶效应。目前的努力集中在靶向共伴侣上,以开发针对许多由蛋白质质量控制缺陷引起的疾病的精确治疗方法。本综述重点介绍了选定的 HSP70/HSP90 共伴侣的最新研究进展,重点关注心脏保护、神经保护、癌症和自身免疫性疾病。我们还讨论了治疗方法,强调了靶向共伴侣的实用性和挑战。